Kestra Investment Management’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
3,206
-1,539
-32% -$647K 0.03% 171
2026
Q1
$1.79M Buy
4,745
+1,738
+58% +$744K 0.03% 143
2025
Q4
$1.29M Buy
3,007
+1,181
+65% +$514K 0.03% 177
2025
Q3
$817K Sell
1,826
-91
-5% -$41.2K 0.02% 218
2025
Q2
$934K Buy
1,917
+197
+11% +$112K 0.03% 199
2025
Q1
$1.06M Buy
1,720
+660
+62% +$375K 0.03% 162
2024
Q4
$561K Buy
1,060
+62
+6% +$35K 0.02% 212
2024
Q3
$600K Buy
+998
New +$566K 0.03% 184

Other funds holding CHE

Kestra Investment Management's CHE Position: Q2 2026 in Review

Kestra Investment Management reduced its Chemed (CHE) stake by 32% in Q2 2026, selling an estimated $647K and leaving 3,206 shares worth $1.49M. The position accounts for 0.03% of the portfolio, ranked #171.

Kestra Investment Management first reported a position in CHE in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.79M in Q1 2026. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Kestra Investment Management held 3,206 shares of Chemed worth $1.49M as of Q2 2026.
  • Kestra Investment Management sold 1,539 Chemed shares in Q2 2026, an estimated $647K.
  • Chemed made up 0.03% of Kestra Investment Management's portfolio in Q2 2026, its #171 holding.
  • Kestra Investment Management first reported a position in Chemed in Q3 2024 and has held it in 8 quarters since.
  • Kestra Investment Management's Chemed position peaked at $1.79M in Q1 2026.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Kestra Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.